Spots Global Cancer Trial Database for octreotide acetate
Every month we try and update this database with for octreotide acetate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery | NCT01229943 | Advanced Pancre... Locally Advance... Pancreatic Gast... Pancreatic Neur... Pancreatic Neur... Pancreatic Vipo... | Bevacizumab Everolimus Octreotide Acet... | 18 Years - | National Cancer Institute (NCI) | |
| Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer | NCT00006269 | Colorectal Canc... Diarrhea | irinotecan hydr... octreotide acet... | 18 Years - | Novartis | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery | NCT03734627 | Esophageal Canc... Nutrition Disor... Appetite Disord... Dumping Syndrom... Delayed Gastric... Surgery | Octreotide Acet... Saline Solution Paracetamol Sulfasalazine Duodenal biopsy | 18 Years - | St. James's Hospital, Ireland | |
| Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel | NCT01469338 | Diarrhea Hormone-resista... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | cabazitaxel prednisone octreotide pamo... questionnaire a... octreotide acet... | 18 Years - | University of Southern California | |
| Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma | NCT00003283 | Thymoma and Thy... | octreotide acet... prednisone | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor | NCT00569127 | Colorectal Neur... Gastric Neuroen... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... | Bevacizumab Laboratory Biom... Octreotide Acet... Recombinant Int... | - | National Cancer Institute (NCI) | |
| Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma | NCT00002779 | Lymphoma | fludarabine pho... octreotide acet... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Octreotide and Doxorubicin in Treating Patients With Advanced Cancer | NCT00008073 | Unspecified Adu... | doxorubicin hyd... octreotide acet... | 18 Years - | University of Pittsburgh | |
| Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor | NCT00569127 | Colorectal Neur... Gastric Neuroen... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... | Bevacizumab Laboratory Biom... Octreotide Acet... Recombinant Int... | - | National Cancer Institute (NCI) | |
| Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors | NCT00227773 | Gastrointestina... Islet Cell Carc... | octreotide acet... vatalanib anti-cytokine t... antiangiogenesi... biological ther... endocrine thera... enzyme inhibito... growth factor a... hormone therapy protein tyrosin... somatostatin an... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | NCT00033605 | Cervical Cancer Colorectal Canc... Diarrhea Endometrial Can... Fallopian Tube ... Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... Vaginal Cancer Vulvar Cancer | octreotide acet... placebo radiation | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer | NCT00257426 | Liver Cancer | octreotide acet... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | NCT00033605 | Cervical Cancer Colorectal Canc... Diarrhea Endometrial Can... Fallopian Tube ... Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... Vaginal Cancer Vulvar Cancer | octreotide acet... placebo radiation | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors | NCT00466856 | Head and Neck C... Islet Cell Tumo... Metastatic Canc... Pheochromocytom... | octreotide acet... yttrium Y 90 re... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer | NCT00006269 | Colorectal Canc... Diarrhea | irinotecan hydr... octreotide acet... | 18 Years - | Novartis | |
| Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer | NCT00003057 | Colorectal Canc... Diarrhea | loperamide hydr... octreotide acet... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Octreotide in Treating Patients With Cancer-Related Malignant Ascites | NCT00182754 | Metastatic Canc... Unspecified Adu... | octreotide acet... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery | NCT01229943 | Advanced Pancre... Locally Advance... Pancreatic Gast... Pancreatic Neur... Pancreatic Neur... Pancreatic Vipo... | Bevacizumab Everolimus Octreotide Acet... | 18 Years - | National Cancer Institute (NCI) | |
| Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors | NCT00227773 | Gastrointestina... Islet Cell Carc... | octreotide acet... vatalanib anti-cytokine t... antiangiogenesi... biological ther... endocrine thera... enzyme inhibito... growth factor a... hormone therapy protein tyrosin... somatostatin an... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel | NCT01469338 | Diarrhea Hormone-resista... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | cabazitaxel prednisone octreotide pamo... questionnaire a... octreotide acet... | 18 Years - | University of Southern California | |
| Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer | NCT00002864 | Breast Cancer | octreotide acet... tamoxifen citra... | - 120 Years | Canadian Cancer Trials Group | |
| Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel | NCT01469338 | Diarrhea Hormone-resista... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | cabazitaxel prednisone octreotide pamo... questionnaire a... octreotide acet... | 18 Years - | University of Southern California | |
| Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer | NCT00003057 | Colorectal Canc... Diarrhea | loperamide hydr... octreotide acet... | 18 Years - 120 Years | Eastern Cooperative Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
